Inflaminat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inflaminat, covering 2012-12-06 to 2012-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis [Phase 2]